Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Streetwise Reports
The Gold Report
The Energy Report
more_reports

Streetwise ReportsThe Life Sciences Report

  • Menu
  • Articles
    • Biotechnology / Pharmaceuticals
    • Cannabis
    • Healthcare Services
    • Life Sciences Tools & Diagnostics
    • Medical Devices
    • Nutraceuticals
    • Psychedelics
    • Regenerative Medicine

Featured news in The Life Sciences Report

ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Announces Debt Amendment and Conversion (6/22/2022)
view
 

ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application (6/22/2022)
view
 

ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares (6/22/2022)
view
 


Athersys Inc. (ATHX:NASDAQ)
Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and Director Departures (6/21/2022)
view
 


Avivagen Inc. (VIV:TSX.V; VIVXF:OTCQB)
Avivagen Inc. Announces Options Grant (6/20/2022)
view
  • Subscribe
  • About
  • Disclaimer
  • Contact
  • Sponsorship
  • Syndication
  • Careers
  • Policies
FacebookTwitterEmailRSS FeedPrint This

© 2022 Streetwise Reports. All rights reserved.

Streetwise Reports is registered with the U.S. Patent and Trademark Office.

Streetwise Reports